Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase EARLY_PHASE1 1Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 4Pain 3Neoplasms 3Breast Neoplasms 2Urinary Bladder Neoplasms 1Pneumonia 1Patient Satisfaction 1Paget Disease, Extramammary 1Operable Breast Cancer 1Myofascial Pain Syndromes 1Lymphoma, Follicular 1Lung Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Chronic Pain 1Cancer Pain 1Agnosia 1

Interventions

Fluorouracil 131Leucovorin 127Oxaliplatin 93Bevacizumab 86Irinotecan 74Capecitabine 63Cetuximab 47Folfox protocol 32Panitumumab 18regorafenib 16trifluridine tipiracil drug combination 15Drug Therapy 14Chemotherapy, Adjuvant 13IFL protocol 10Floxuridine 10Radiotherapy 9Tegafur 7Neoadjuvant Therapy 7Levoleucovorin 7Laparoscopy 7Aspirin 7pembrolizumab 6atezolizumab 6Trifluridine 6Celecoxib 6XELOX 5Mitomycin 5Colonoscopy 5tipiracil 4sintilimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Colorectal Neoplasms × Lidocaine × Clear all
NCT00236249 2011-02-18

Safety and Efficacy Study of Intravenous Lidocaine After Colorectal Surgery: LIDOREHAB

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
110 enrolled
Gastrointestinal

Agnosia, Pain, Postoperative, Colorectal Neoplasms, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡